Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.953 USD | +6.68% | +36.14% | +18.83% |
04-25 | Transcript : HOOKIPA Pharma Inc. - Special Call | |
04-25 | HOOKIPA Pharma Inc. Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Neutral |
Resistance | 0.9150 | 1.160 | 1.040 |
Spread/Res. | +5.19% | -17.03% | -7.45% |
Spread/Supp. | +18.84% | +50.37% | +123.84% |
Support | 0.8099 | 0.6401 | 0.4300 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- HOOK Stock
- Charts HOOKIPA Pharma Inc.